Matt Phipps
Stock Analyst at William Blair
(3.75)
# 1,922
Out of 4,547 analysts
564
Total ratings
45.5%
Success rate
4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matt Phipps
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Maintained: Hold | n/a | $117.39 | - | 47 | Jul 20, 2026 | |
| ARGX argenx SE | Maintained: Buy | n/a | $874.74 | - | 11 | Jul 20, 2026 | |
| INSM Insmed | Reiterated: Buy | n/a | $108.62 | - | 13 | Jul 16, 2026 | |
| ABBV AbbVie | Maintained: Buy | n/a | $256.10 | - | 11 | Jul 15, 2026 | |
| TENX Tenax Therapeutics | Maintained: Buy | n/a | $15.72 | - | 17 | Jul 15, 2026 | |
| GMAB Genmab | Maintained: Buy | n/a | $28.37 | - | 24 | Jul 14, 2026 | |
| ZURA Zura Bio | Initiated Coverage: Buy | n/a | $5.68 | - | 1 | Jul 8, 2026 | |
| EVMN Evommune | Downgraded: Hold | n/a | $12.22 | - | 16 | Jun 29, 2026 | |
| CNTX Context Therapeutics | Reiterated: Buy | n/a | $0.63 | - | 11 | Jun 15, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | n/a | $13.10 | - | 12 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.06 | - | 21 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.47 | - | 40 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.77 | - | 18 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.53 | - | 5 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.98 | - | 20 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.57 | - | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.00 | - | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 → $14 | $16.26 | -13.90% | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $32.34 | - | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $13 | $20.45 | -36.43% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.10 | - | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $366.24 | - | 38 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $60.93 | - | 58 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $236.95 | - | 1 | Jan 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 | $53.39 | +118.69% | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $105.72 | - | 1 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.58 | - | 19 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.07 | - | 8 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $482.00 | n/a | 1 | Jun 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $59.66 | n/a | 1 | Jun 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9902 | n/a | 5 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.29 | n/a | 11 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.2 | $15.15 | n/a | 1 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8948 | n/a | 13 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $143.94 | n/a | 19 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.63 | n/a | 14 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0001 | n/a | 11 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.90 | n/a | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $203.16 | n/a | 26 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $68.67 | n/a | 1 | Jun 11, 2021 |
Incyte
Jul 20, 2026
Maintained: Hold
Price Target: n/a
Current: $117.39
Upside: -
argenx SE
Jul 20, 2026
Maintained: Buy
Price Target: n/a
Current: $874.74
Upside: -
Insmed
Jul 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $108.62
Upside: -
AbbVie
Jul 15, 2026
Maintained: Buy
Price Target: n/a
Current: $256.10
Upside: -
Tenax Therapeutics
Jul 15, 2026
Maintained: Buy
Price Target: n/a
Current: $15.72
Upside: -
Genmab
Jul 14, 2026
Maintained: Buy
Price Target: n/a
Current: $28.37
Upside: -
Zura Bio
Jul 8, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $5.68
Upside: -
Evommune
Jun 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $12.22
Upside: -
Context Therapeutics
Jun 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.63
Upside: -
Climb Bio
Jun 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.10
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.06
Upside: -
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $1.47
Upside: -
Jun 1, 2026
Maintained: Hold
Price Target: n/a
Current: $0.77
Upside: -
Jun 1, 2026
Maintained: Buy
Price Target: n/a
Current: $20.53
Upside: -
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $6.98
Upside: -
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $10.57
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $6.00
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $71 → $14
Current: $16.26
Upside: -13.90%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $32.34
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $13 → $13
Current: $20.45
Upside: -36.43%
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $2.10
Upside: -
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $366.24
Upside: -
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $60.93
Upside: -
Jan 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $236.95
Upside: -
Oct 11, 2025
Reiterated: Buy
Price Target: $117
Current: $53.39
Upside: +118.69%
Sep 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $105.72
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $5.58
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $11.07
Upside: -
Jun 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $482.00
Upside: n/a
Jun 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $59.66
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $0.9902
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $1.29
Upside: n/a
Mar 29, 2025
Initiated Coverage: Buy
Price Target: $1.2
Current: $15.15
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $0.8948
Upside: n/a
Jan 3, 2022
Maintained: Buy
Price Target: n/a
Current: $143.94
Upside: n/a
Dec 7, 2021
Maintained: Buy
Price Target: n/a
Current: $8.63
Upside: n/a
Dec 7, 2021
Maintained: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: n/a
Current: $0.90
Upside: n/a
Jul 23, 2021
Rated: Buy
Price Target: n/a
Current: $203.16
Upside: n/a
Jun 11, 2021
Maintained: Buy
Price Target: n/a
Current: $68.67
Upside: n/a